At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic diseases.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: haemophilia, growth disorders and obesity.
Headquartered in Denmark,
Novo Nordisk employs approximately 42,700 people in 80 countries and
markets its products in around 170 countries.
The Novo Nordisk Way -
who we are, where we want to go and how we work
Each and every employee is responsible for acting in accordance with the Novo Nordisk Way - and to help each other understand what it means in practice.
The Triple Bottom Line -
our way of doing business
We have built our business on the conviction that the formula for lasting success is to stay focused, think long-term and do business in a financially, socially and environmentally responsible way. That is why we manage our business in accordance with the Triple Bottom Line principle.
The story of Novo Nordisk goes back more than 90 years
It began when August Krogh, a Nobel Prize-winning professor at the University of Copenhagen, decided he wanted to start producing a revolutionary new medical preparation called insulin.